Xwell (XWEL) Net Income towards Common Stockholders Growth (5y) (2016 - 2026)
Xwell (XWEL) Net Income towards Common Stockholders Growth (5y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn |
| 10 | Xwell | 7.47 Mn | -9.34 Mn | 2.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.12% |
| Dec 31, 2025 | -5.67% |
| Sep 30, 2025 | 26.01% |
| Jun 30, 2025 | 44.64% |
| Mar 31, 2025 | 13.19% |
| Jun 30, 2023 | -62.22% |
| Mar 31, 2023 | -55.55% |
| Dec 31, 2022 | -13.30% |
| Sep 30, 2022 | -59.34% |
| Jun 30, 2022 | -28.11% |
| Mar 31, 2022 | -13.32% |
| Dec 31, 2021 | 19.00% |
| Sep 30, 2021 | 72.98% |
| Jun 30, 2021 | -36.50% |
| Mar 31, 2021 | 27.21% |
| Jun 30, 2018 | 6.43% |
| Mar 31, 2018 | 11.35% |
| Dec 31, 2017 | 7.61% |
| Sep 30, 2017 | 25.88% |
| Jun 30, 2017 | -4.53% |